X4 PHARMACEUTICALS, INC (XFOR) Capital expenditures 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $73,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $326,000 | +443.3% |
| FY2023 | $60,000 | -41.7% |
| FY2022 | $103,000 | -83.3% |
| FY2021 | $615,000 | -54.8% |
| FY2020 | $1.4M | +682.8% |
| FY2019 | $174,000 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $378,000 | +417.8% |
| FY2016 | $73,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice